about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Pfiz­er pitch­es 4th Covid-19 vac­cine shot for el­der­ly de­spite mixed da­ta from Is­rael

4 years ago
FDA+
Coronavirus

Pushed out of Eli Lil­ly in ethics scan­dal, Josh Smi­ley lands a top job at Zai Lab

4 years ago
People

No­vo Nordisk, Gates Foun­da­tion pledge $90M to fund an­tivi­ral re­search for the next pan­dem­ic

4 years ago
R&D
Discovery

Root­ing for a come-from-be­hind win, Black­stone in­fus­es $330M in­to Sanofi's CD38 de­vel­op­ment plan

4 years ago
R&D

Ex­elix­is throws in the tow­el on ear­ly-stage liv­er can­cer af­ter fi­nal read­out shows OS flop

4 years ago
R&D

No more busi­ness as usu­al: Pfiz­er, Bay­er and Sanofi step up ac­tions against Rus­sia amid grow­ing pres­sure to ex­it

4 years ago
Pharma

Mov­ing up the treat­ment lines, As­traZeneca clinch­es ad­ju­vant breast can­cer OK for Lyn­parza

4 years ago
Pharma
FDA+

FDA hits back Fasen­ra in key rhi­nos­i­nusi­tis field, putting As­traZeneca even fur­ther be­hind Big Phar­ma ri­vals

4 years ago
Pharma
FDA+

Sanofi's first big tri­al for top can­cer drug ends in set­back

4 years ago
R&D

Re­vamp com­ing at Gilead; Lat­est from in Ukraine, Rus­sia; Bio­gen’s hang­ing bud­get ax; No­var­tis places gene ther­a­py ...

4 years ago
Weekly

SEC sin­gles out Zai Lab, BeiGene, Hutchmed for reg­u­la­to­ry scruti­ny — with threats of delist­ing

4 years ago
China
FDA+

The of­fer does­n't stop at Covid. No­var­tis opens up man­u­fac­tur­ing ops to make Caris­ma’s CAR-M cell ther­a­py

4 years ago
Pharma
Cell/Gene Tx

Aim­ing to drug ge­net­ic mod­i­fiers, Roche-part­nered biotech bags $31M to fu­el a dri­ve to­ward clin­ic

4 years ago
Financing

Big Phar­ma hits pause on tri­als in Rus­sia, Ukraine as they ramp up hu­man­i­tar­i­an aid

4 years ago
Pharma

Black­stone leads $200M in­jec­tion in­to da­ta analy­sis soft­ware mak­er

4 years ago
Financing

Lu­l­ule­mon founder com­mits $100M to cure his rare dis­ease

4 years ago
R&D
Discovery

Sher­lock, Feng Zhang's CRISPR di­ag­nos­tic out­fit, grabs $80M to go be­yond Covid-19

4 years ago
Financing
Diagnostics

No­var­tis takes a gam­ble on Voy­ager's new AAV tech, inks $1.7B gene ther­a­py dis­cov­ery pact

4 years ago
Deals
Cell/Gene Tx

John Maraganore joins up with Pro­QR as strate­gic ad­vi­sor; Servi­er nabs pri­or­i­ty re­view for Tib­so­vo sN­DA

4 years ago
News Briefing

Nasal spray mak­er clinch­es first PhI­II win it needs to reach a much, much big­ger mar­ket

4 years ago
R&D

Bris­tol My­ers re­serves a cen­ter spot at Alexan­dri­a's big San Diego biotech R&D hub

4 years ago
Pharma

Blue­bird CFO re­signs as com­pa­ny faces bleak eco­nom­ic fu­ture

4 years ago
People
Pharma

The Pfiz­er pa­pers; Bio­gen lay­offs be­gin; Ab­b­Vie inks a buy­out; GSK makes Slaoui pay; and more

4 years ago
Weekly

In the wake of pa­tient death, Sutro says its Chi­nese part­ner is re­think­ing their deal and with­hold­ing $40M

4 years ago
Deals
First page Previous page 35363738394041 Next page Last page
A service from the Financial Times